Telehealth for Women's Preventive Services for Reproductive Health and Intimate Partner Violence: a Comparative Effectiveness Review.


Journal

Journal of general internal medicine
ISSN: 1525-1497
Titre abrégé: J Gen Intern Med
Pays: United States
ID NLM: 8605834

Informations de publication

Date de publication:
05 2023
Historique:
received: 09 11 2022
accepted: 30 12 2022
medline: 29 5 2023
pubmed: 18 1 2023
entrez: 17 1 2023
Statut: ppublish

Résumé

Telehealth delivery of preventive health services may improve access to care; however, its effectiveness and adverse effects are unknown. We conducted a comparative effectiveness review on the effectiveness and harms of telehealth interventions for women's reproductive health and intimate partner violence (IPV) services. We searched MEDLINE, Cochrane Library, CINAHL, and Scopus for English-language studies (July 2016 to May 2022) for randomized controlled trials (RCTs) and observational studies of telehealth strategies for women's reproductive health and IPV versus usual care. Two investigators identified studies and abstracted data using a predefined protocol. Study quality was assessed using study design-specific standardized methods; disagreements were resolved through consensus. Eight RCTs, 1 nonrandomized trial, and 7 observational studies (n=10 731) were included (7 studies of contraceptive care and 9 of IPV services). Telehealth interventions to supplement contraceptive care demonstrated similar rates as usual care for contraceptive use, sexually transmitted infections, and pregnancy (low strength of evidence [SOE]); evidence on abortion was insufficient. Outcomes were also similar between telehealth interventions to replace or supplement IPV services and comparators for repeat IPV, depression, posttraumatic stress disorder, fear of partner, coercive control, self-efficacy, and safety behaviors (low SOE). In these studies, telehealth barriers included limited internet access, digital literacy, technical challenges, and confidentiality concerns. Strategies to ensure safety increased telehealth use for IPV services. Evidence on access, health equity, or harms was lacking. Telehealth interventions for contraceptive care and IPV services demonstrate equivalent clinical and patient-reported outcomes versus in-person care, although few studies are available. Effective approaches for delivering these services and how to best mobilize telehealth, particularly for women facing barriers to care remain uncertain. PROSPERO CRD42021282298.

Sections du résumé

BACKGROUND
Telehealth delivery of preventive health services may improve access to care; however, its effectiveness and adverse effects are unknown. We conducted a comparative effectiveness review on the effectiveness and harms of telehealth interventions for women's reproductive health and intimate partner violence (IPV) services.
METHODS
We searched MEDLINE, Cochrane Library, CINAHL, and Scopus for English-language studies (July 2016 to May 2022) for randomized controlled trials (RCTs) and observational studies of telehealth strategies for women's reproductive health and IPV versus usual care. Two investigators identified studies and abstracted data using a predefined protocol. Study quality was assessed using study design-specific standardized methods; disagreements were resolved through consensus.
RESULTS
Eight RCTs, 1 nonrandomized trial, and 7 observational studies (n=10 731) were included (7 studies of contraceptive care and 9 of IPV services). Telehealth interventions to supplement contraceptive care demonstrated similar rates as usual care for contraceptive use, sexually transmitted infections, and pregnancy (low strength of evidence [SOE]); evidence on abortion was insufficient. Outcomes were also similar between telehealth interventions to replace or supplement IPV services and comparators for repeat IPV, depression, posttraumatic stress disorder, fear of partner, coercive control, self-efficacy, and safety behaviors (low SOE). In these studies, telehealth barriers included limited internet access, digital literacy, technical challenges, and confidentiality concerns. Strategies to ensure safety increased telehealth use for IPV services. Evidence on access, health equity, or harms was lacking.
DISCUSSION
Telehealth interventions for contraceptive care and IPV services demonstrate equivalent clinical and patient-reported outcomes versus in-person care, although few studies are available. Effective approaches for delivering these services and how to best mobilize telehealth, particularly for women facing barriers to care remain uncertain.
TRIAL REGISTRATION
PROSPERO CRD42021282298.

Identifiants

pubmed: 36650334
doi: 10.1007/s11606-023-08033-6
pii: 10.1007/s11606-023-08033-6
pmc: PMC9845023
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

Systematic Review Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1735-1743

Informations de copyright

© 2023. The Author(s), under exclusive licence to Society of General Internal Medicine.

Références

Healthcare (Basel). 2020 Oct 01;8(4):
pubmed: 33019667
Prev Med. 2021 Sep;150:106664
pubmed: 34081938
Contraception. 2012 Dec;86(6):716-24
pubmed: 22840278
Crim Behav Ment Health. 2015 Dec 10;25(4):314-29
pubmed: 26482019
Am J Public Health. 2016 Sep;106(S1):S117-S124
pubmed: 27689478
J Adolesc Health. 2021 Sep;69(3):375-382
pubmed: 34301467
J Gen Intern Med. 2018 Dec;33(12):2191-2200
pubmed: 30284173
Am J Manag Care. 2020 Apr;26(4):147-148
pubmed: 32270980
Am J Nurs. 2004 Mar;104(3):40-50; quiz 50-1
pubmed: 15108570
JMIR Public Health Surveill. 2020 Apr 7;6(2):e18961
pubmed: 32250963
JMIR Aging. 2020 Nov 10;3(2):e23176
pubmed: 33048821
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
JAMA. 2022 Nov 1;328(17):1768-1770
pubmed: 36318139
Contraception. 2021 Sep;104(3):262-264
pubmed: 34058223
Obstet Gynecol. 2020 Feb;135(2):371-382
pubmed: 31977782
J Gen Intern Med. 2015 Mar;30(3):271-2
pubmed: 25588688
J Med Internet Res. 2018 Jan 10;19(12):e426
pubmed: 29321125
Womens Health Issues. 2017 Jul - Aug;27(4):420-425
pubmed: 28284586
Lancet Public Health. 2019 Jun;4(6):e301-e310
pubmed: 31155223
J Med Internet Res. 2021 Feb 19;23(2):e22790
pubmed: 33605898
J Adolesc Health. 2017 Dec;61(6):786-790
pubmed: 29056437
Contraception. 2021 Sep;104(3):254-261
pubmed: 33861981
J Clin Epidemiol. 2014 Jan;67(1):56-64
pubmed: 24189091
Contraception. 2022 Aug;112:86-92
pubmed: 35247368
Am J Prev Med. 2017 May;52(5):606-615
pubmed: 28108189
Contraception. 2021 Mar;103(3):157-162
pubmed: 33212033
PLoS One. 2019 Jun 11;14(6):e0217902
pubmed: 31185058
Ann Epidemiol. 2014 Feb;24(2):144-50
pubmed: 24252714
BMC Public Health. 2020 Feb 26;20(1):260
pubmed: 32098633
Health Care Women Int. 2020 Nov-Dec;41(11-12):1294-1312
pubmed: 33085577

Auteurs

Amy G Cantor (AG)

Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. cantor@ohsu.edu.
Department of Family Medicine, School of Medicine, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. cantor@ohsu.edu.
Department of Obstetrics and Gynecology, School of Medicine, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA. cantor@ohsu.edu.

Heidi D Nelson (HD)

Kaiser Permanente Bernard D. Tyson School of Medicine, Pasadena, CA, USA.

Miranda Pappas (M)

Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Chandler Atchison (C)

Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Brigit Hatch (B)

Department of Family Medicine, School of Medicine, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Nathalie Huguet (N)

Department of Family Medicine, School of Medicine, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Brittny Flynn (B)

Oregon Health & Science University, School of Medicine, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Marian McDonagh (M)

Pacific Northwest Evidence-Based Practice Center, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, BICC; 3181 SW Sam Jackson Park Road, Portland, OR, 97239, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH